Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Neoplasms 4Breast Neoplasms 3Recurrence 2Neoplasm Metastasis 2Malignant Neoplasms of Independent (Primary) Multiple Sites 2Lung Neoplasms 2Endometrial Neoplasms 2Colorectal Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Tobacco Use Cessation 1Smoking Cessation 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Patient Participation 1Ovarian Neoplasms 1Narration 1Hereditary Breast and Ovarian Cancer Syndrome 1Constipation 1Caregiver 1Anxiety Disorders 1Advanced Gastrointestinal Cancer 1Advanced Cancers 1Advanced Cancer 1

Interventions

Carboplatin 41Paclitaxel 40pembrolizumab 38Cyclophosphamide 23Gemcitabine 22130-nm albumin-bound paclitaxel 21Doxorubicin 18Cisplatin 18Albumin-Bound Paclitaxel 18atezolizumab 16Taxes 15Capecitabine 13veliparib 10Nivolumab 9Docetaxel 9Bevacizumab 9olaparib 8liposomal doxorubicin 7Everolimus 7spartalizumab 6durvalumab 6Epirubicin 6trametinib 5pegfilgrastim 5eribulin 5Irinotecan 5Filgrastim 5iniparib 4binimetinib 4apatinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Triple Negative Breast Neoplasms × Videotape Recording × Clear all
NCT02451735 2019-11-08

Genetic Counseling for Breast Cancer Survivors (GC for BC)

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
157 enrolled
BreastGynecologic

Breast Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡